Home » Newsletters » BioWorld Science

BioWorld Science

March 29, 2006

View Archived Issues

Pfizer presents novel renin inhibitors at 231st ACS National Meeting

Johnson & Johnson profile their new 11beta-HSD1 inhibitor

DIN-106935: a mixed ion channel inhibitor

AMG-131: novel modulator of PPARgamma for type 2 diabetes

Two activators of ferric sGC from sanofi-aventis

Antiproliferative efficacy of BMS-554417, an IGF-IR inhibitor

Korean approval for Quinvaxem pentavalent vaccine

Eisai seeks Japanese approval for Pariet in nonerosive GERD

Draximage realigns R&D priorities

Immtech begins pivotal study of pafuramidine maleate

Idera secures funding to advance pipeline

Elixir acquires rights to Glufast

Geron signs agreements with U. of Oxford for dendritic cell production

FemmePharma opens IND for topical cream to treat breast pain

Chinese data support efficacy of telbivudine in chronic hepatitis B

Akzo Nobel updates pipeline status

SD's nano-emulsion paclitaxel formulation demonstrates efficacy in preclinical tests

Japanese cooperative marketing of Abbott and Dainippon Sumitomo comes to end

Lundbeck begins phase I trials for Lu-AA34893 for depression

Rituximab well tolerated, beneficial in steroid-refractory graft-versus-host disease

Recent patents disclose novel antiinfective agents

New treatments for hepatitis C described in recent patent literature

Additional treatment and switching therapy effective in treating resistant depression

New analgesic agents imparted in recent patents

New study data on 7-valent vaccination for invasive pneumococcal disease presented

Exelixis advances XL-784 into phase II for diabetic nephropathy

Levemir made available in U.S.

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...